Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Han L, Myers RP, Subramanian GM, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR (2017) The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial
It combines R-ALA with other nutrients to enhance energy production, reduce fatigue, fight age-accelerating free radicals and support overall vitality at a cellular level
Taking these together ensures both the interior and the exterior of your cells are well-defended
Historically, POI was referred to as premature ovarian failure (POF), though the term POF is considered inaccurate, as patients with POF still have a 510% chance of conceiving
The clinical trial data confirms it, as we will examine in detail in the next section
Increased NO activity can promote wakefulness and alertness in the short term (PubMed)